Citations (138)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yanjie You, Yuhong Ma, Qiang Wang, Zhengcai Ye, Yanhong Deng & Feihu Bai. (2019) Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients. Cancer Management and Research 11, pages 1199-1210.
Read now
Read now
Venkata Talluri Siddhartha, Sai Kiran S. S. Pindiprolu, Pavan Kumar Chintamaneni, Shashank Tummala & S. Nandha Kumar. (2018) RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies. Artificial Cells, Nanomedicine, and Biotechnology 46:2, pages 387-397.
Read now
Read now
David P Boyle, Clare M McCourt, Kyle B Matchett & Manuel Salto-Tellez. (2013) Molecular and clinicopathological markers of prognosis in breast cancer. Expert Review of Molecular Diagnostics 13:5, pages 481-498.
Read now
Read now
Alexandra Hebar, Peter Valent & Edgar Selzer. (2013) The impact of molecular targets in cancer drug development: major hurdles and future strategies. Expert Review of Clinical Pharmacology 6:1, pages 23-34.
Read now
Read now
Chad J Creighton. (2012) The molecular profile of luminal B breast cancer. Biologics: Targets and Therapy 6, pages 289-297.
Read now
Read now
Anastasia Constantinidou, Robin L Jones & Jorge S Reis-Filho. (2010) Beyond triple-negative breast cancer: the need to define new subtypes. Expert Review of Anticancer Therapy 10:8, pages 1197-1213.
Read now
Read now
Articles from other publishers (132)
Joshua Levy & Louis Vaickus. 2024. Diagnostic Molecular Pathology. Diagnostic Molecular Pathology
687
730
.
Alireza Shariatmadar Taleghani, Yasaman Zohrab Beigi, Fatemeh Zare-Mirakabad & Ali Masoudi-Nejad. (2023) Exploring ceRNA networks for key biomarkers in breast cancer subtypes and immune regulation. Scientific Reports 13:1.
Crossref
Crossref
Ulas Yalim Uncu & Sibel Aydin Aksu. (2023) Correlation of Perfusion Metrics with Ki-67 Proliferation Index and Axillary Involvement as a Prognostic Marker in Breast Carcinoma Cases: A Dynamic Contrast-Enhanced Perfusion MRI Study. Diagnostics 13:20, pages 3260.
Crossref
Crossref
Jayhind L BhartiAnjali M WankhadeJ V VyasVivek V PaithankarPratiksha R Morey. (2023) A Review on Current and Novel Treatment Regimen on Luminal A Breast Cancer. Asian Journal of Pharmacy and Technology, pages 115-122.
Crossref
Crossref
Omid Bakhtar. (2023) Pathology of Breast Cancer. Surgical Clinics of North America 103:1, pages 1-15.
Crossref
Crossref
Yonghui Ni, Jianghua He & Prabhakar Chalise. (2023) Randomized singular value decomposition for integrative subtype analysis of ‘omics data’ using non-negative matrix factorization. Statistical Applications in Genetics and Molecular Biology 22:1.
Crossref
Crossref
Ziyi Fu, Siqi Chen, Yueming Zhu, Donghong Zhang, Ping Xie, Qiao Jiao, Junlong Chi, Shipeng XuYifan Xue, Xinghua Lu, Xinxin SongMassimo Cristofanilli, William J. GradisharKevin KalinskyYongmei Yin, Bin Zhang & Yong Wan. (2023) Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity. Science Advances 9:1.
Crossref
Crossref
Suvobrata Sarkar & Kalyani Mali. (2023) Firefly-SVM predictive model for breast cancer subgroup classification with clinicopathological parameters. DIGITAL HEALTH 9.
Crossref
Crossref
Valeria Villarreal-García, José Roberto Estupiñan-Jiménez, Pablo E. Vivas-Mejía, Vianey Gonzalez-Villasana, José Manuel Vázquez-Guillén & Diana Reséndez-Pérez. (2022) A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs. Frontiers in Oncology 12.
Crossref
Crossref
Suvobrata Sarkar & Kalyani Mali. (2022) Breast Cancer Subtypes Classification with Hybrid Machine Learning Model. Methods of Information in Medicine 61:03/04, pages 068-083.
Crossref
Crossref
K. IndumathiDr.Dr., E. TheranirajanDr.Dr. & G. BhavaniDr.Dr.. (2021) COMPARISON OF CLINICOPATHOLOGICAL PARAMETERS WITH HISTOLOGICAL AND MOLECULAR CLASSIFICATION OF BREAST CANCERS. GLOBAL JOURNAL FOR RESEARCH ANALYSIS, pages 144-149.
Crossref
Crossref
Youhong Luo, Hui Liu, Chunye Wu, Maria Paraskevaidi, Yujie Deng, Wenjie Shi, Ye Yuan, Ruifa Feng, Francis L. Martin & Weiyi Pang. (2021) Diagnostic segregation of human breast tumours using Fourier-transform infrared spectroscopy coupled with multivariate analysis: Classifying cancer subtypes. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 255, pages 119694.
Crossref
Crossref
Xiufang Xu, Miaofeng Zhang, Faying Xu & Shaojie Jiang. (2020) Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. Molecular Cancer 19:1.
Crossref
Crossref
Narjes Rohani & Changiz Eslahchi. (2020) Classifying Breast Cancer Molecular Subtypes by Using Deep Clustering Approach. Frontiers in Genetics 11.
Crossref
Crossref
Veli S. Öztürk, Yasemin D. Polat, Aykut Soyder, Ahmet Tanyeri, Can Z. Karaman & Füsun Taşkın. (2020) The Relationship Between MRI Findings and Molecular Subtypes in Women With Breast Cancer. Current Problems in Diagnostic Radiology 49:6, pages 417-421.
Crossref
Crossref
Erik Kudela, Marek Samec, Lenka Koklesova, Alena Liskova, Peter Kubatka, Erik Kozubik, Tomas Rokos, Terezia Pribulova, Eva Gabonova, Marek Smolar & Kamil Biringer. (2020) miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment. International Journal of Molecular Sciences 21:20, pages 7691.
Crossref
Crossref
Jie Yi, Liwen Ren, Dandan Li, Jie Wu, Wan Li, Guanhua Du & Jinhua Wang. (2020) Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers. Biomedicine & Pharmacotherapy 124, pages 109827.
Crossref
Crossref
Julia Y.S. Tsang & Gary M. Tse. (2020) Molecular Classification of Breast Cancer. Advances in Anatomic Pathology 27:1, pages 27-35.
Crossref
Crossref
Hugo Vilhena, Ana Catarina Figueira, Fernando Schmitt, Ana Canadas, Raquel Chaves, Adelina Gama & Patrícia Dias-Pereira. 2020. Pets as Sentinels, Forecasters and Promoters of Human Health. Pets as Sentinels, Forecasters and Promoters of Human Health
173
207
.
Alfred Grant Schissler, Dillon Aberasturi, Colleen Kenost & Yves A. Lussier. (2019) A Single-Subject Method to Detect Pathways Enriched With Alternatively Spliced Genes. Frontiers in Genetics 10.
Crossref
Crossref
Long Yuan, Fan Zhang, Xiaowei Qi, Yongjun Yang, Chang Yan, Jun Jiang & Jun Deng. (2018) Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation. Journal of Nanobiotechnology 16:1.
Crossref
Crossref
E. Dirican & E. Kiliç. (2018) A Machine Learning Approach for the Association of ki-67 Scoring with Prognostic Factors. Journal of Oncology 2018, pages 1-7.
Crossref
Crossref
Cuiyan Wang, Wei Wei, Lumarie Santiago, Gary Whitman & Basak Dogan. (2017) Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?. Acta Radiologica 59:7, pages 813-821.
Crossref
Crossref
Seung Joon Lee, Ji Su Lee, Eunjung Lee, Tae-Gyu Lim & Sanguine Byun. (2018) The ginsenoside metabolite compound K inhibits hormone-independent breast cancer through downregulation of cyclin D1. Journal of Functional Foods 46, pages 159-166.
Crossref
Crossref
Yumin Chung, Young Chan Wi, Yeseul Kim, Seong Sik Bang, Jung-Ho Yang, Kiseok Jang, Kyueng-Whan Min & Seung Sam Paik. (2018) The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma. Journal of Pathology and Translational Medicine 52:1, pages 37-44.
Crossref
Crossref
Bharti Jasra, Astrid Botty Van den Bruele, D. Scott Lind & Edward M. CopelandIIIIII. 2018. The Breast. The Breast
981
992.e3
.
Hans-Peter Sinn, Andreas Schneeweiss, Marius Keller, Kornelia Schlombs, Mark Laible, Julia Seitz, Sotirios Lakis, Elke Veltrup, Peter Altevogt, Sebastian Eidt, Ralph M. Wirtz & Frederik Marmé. (2017) Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer. BMC Cancer 17:1.
Crossref
Crossref
Jia Wu, Xiaoli Sun, Jeff Wang, Yi Cui, Fumi Kato, Hiroki Shirato, Debra M. Ikeda & Ruijiang Li. (2017) Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation. Journal of Magnetic Resonance Imaging 46:4, pages 1017-1027.
Crossref
Crossref
Lynn N. Thomas, Emily R. Chedrawe, Penelope J. Barnes & Catherine K. L. Too. (2017) Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro. Breast Cancer Research and Treatment 164:1, pages 27-40.
Crossref
Crossref
Julia White. (2017) New Approaches for Tailoring the Use of Radiotherapy in Early-Stage Breast Cancer. Current Breast Cancer Reports 9:2, pages 129-136.
Crossref
Crossref
He JingSong, Guan Hong, Jianbo Yang, Zheng Duo, Fu Li, Chen WeiCai, Luo XueYing, Mao YouSheng, OuYang YiWen, Pan Yue & Chang Zou. (2016) siRNA-Mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration. Oncotarget 8:2, pages 2585-2593.
Crossref
Crossref
Matthias W. Beckmann, Charlotte S. Sell & Peter Andreas Fasching. 2017. Mammadiagnostik. Mammadiagnostik
43
53
.
Kyueng-Whan Min, Dong-Hoon Kim, Sung-Im Do, Jung-Soo Pyo, Seoung Wan Chae, Jin Hee Sohn, Kyungeun Kim, Hyun Joo Lee, Dong Hyun Kim, Sukjoong Oh, Seon Hyeong Choi, Yong Lai Park, Chan Heun Park, Mi Jung Kwon & Kyoung Min Moon. (2016) High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer. Postgraduate Medical Journal 92:1094, pages 707-714.
Crossref
Crossref
Milou Tenhagen, Sjoerd Klarenbeek, Tanya M. Braumuller, Ilse Hofmann, Petra van der Groep, Natalie ter Hoeve, Elsken van der Wall, Jos Jonkers & Patrick W. B. Derksen. (2016) p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice. Journal of Mammary Gland Biology and Neoplasia 21:3-4, pages 81-88.
Crossref
Crossref
Vida Pourteimoor, Samira Mohammadi-Yeganeh & Mahdi Paryan. (2016) Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications. Tumor Biology 37:11, pages 14479-14499.
Crossref
Crossref
Peter Keating, Alberto Cambrosio & Nicole C. Nelson. (2016) “Triple negative breast cancer”: Translational research and the (re)assembling of diseases in post-genomic medicine. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 59, pages 20-34.
Crossref
Crossref
Renata A. Canevari, Fabio A. Marchi, Maria A. C. Domingues, Victor Piana de Andrade, José R. F. Caldeira, Sergio Verjovski-Almeida, Silvia R. Rogatto & Eduardo M. Reis. (2016) Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma. Tumor Biology 37:10, pages 13855-13870.
Crossref
Crossref
Suleyman Vural, Xiaosheng Wang & Chittibabu Guda. (2016) Classification of breast cancer patients using somatic mutation profiles and machine learning approaches. BMC Systems Biology 10:S3.
Crossref
Crossref
Kyueng-Whan Min, Dong-Hoon Kim, Sung-Im Do, Seoung Wan Chae, Kyungeun Kim, Jin Hee Sohn, Jung-Soo Pyo, Hyun Joo Lee, Dong Hyun Kim, Sukjoong Oh, Seon Hyeong Choi, Yong Lai Park, Chan Heun Park, Eun-Kyung Kim, Mi Jung Kwon, Jinwon Seo & Kyoung Min Moon. (2015) Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer. Virchows Archiv 468:4, pages 409-416.
Crossref
Crossref
Yanjie You, Haijun Li, Xin Qin, Yonggang Ran & Fei Wang. (2015) Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis - A short Report. Cellular Oncology 39:1, pages 89-95.
Crossref
Crossref
Elizabeth M. Slocum & Irene K. Guttilla Reed. (2015) MicroRNA-100 targets IGF1R and regulates migration in a breast cancer model of epithelial-mesenchymal transition. BIOS 86:4, pages 185-192.
Crossref
Crossref
Chao-Qun Hong, Fan Zhang, Yan-Jie You, Wei-Li Qiu, Armando E. Giuliano, Xiao-Jiang Cui, Guo-Jun Zhang & Yu-Kun Cui. (2015) Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study. BMC Cancer 15:1.
Crossref
Crossref
Yanjie You, Haijun Li, Xin Qin, Yinpo Zhang, Wengang Song, Yonggang Ran & Fenglan Gao. (2015) Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report. Cellular Oncology 38:6, pages 485-491.
Crossref
Crossref
CHUNG-HSIN TSAI, JEN-HWEY CHIU, CHU-WEN YANG, JIR-YOU WANG, YI-FANG TSAI, LING-MING TSENG, WEI-SHONE CHEN & YI-MING SHYR. (2015) Molecular characteristics of recurrent triple-negative breast cancer. Molecular Medicine Reports 12:5, pages 7326-7334.
Crossref
Crossref
Xiao-Long Wei, Xiao-Wei Dou, Jing-Wen Bai, Xiang-Rong Luo, Si-Qi Qiu, Di-Di Xi, Wen-He Huang, Cai-Wen Du, Kwan Man & Guo-Jun Zhang. (2015) ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer. Oncotarget 6:25, pages 21704-21717.
Crossref
Crossref
Ahmed A. Ejaeidi, Barbara S. Craft, Louis V. Puneky, Robert E. Lewis & Julius M. Cruse. (2015) Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis. Experimental and Molecular Pathology 99:1, pages 163-172.
Crossref
Crossref
KYUENG-WHAN MIN, SEOUNG WAN CHAE, DONG-HOON KIM, SUNG-IM DO, KYUNGEUN KIM, HYUN JOO LEE, JIN HEE SOHN, JUNG-SOO PYO, DONG HYUN KIM, SUKJOONG OH, SEON HYEONG CHOI, YONG LAI PARK & CHAN HEUN PARK. (2015) Fascin expression predicts an aggressive clinical course in patients with advanced breast cancer. Oncology Letters 10:1, pages 121-130.
Crossref
Crossref
Heloisa Helena Milioli, Renato Vimieiro, Carlos Riveros, Inna Tishchenko, Regina Berretta & Pablo Moscato. (2015) The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set. PLOS ONE 10:7, pages e0129711.
Crossref
Crossref
Jinsong He, Jianbo Yang, Weicai Chen, Huisheng Wu, Zishan Yuan, Kun Wang, Guojin Li, Jie Sun & Limin Yu. (2015) Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis. PLOS ONE 10:6, pages e0129842.
Crossref
Crossref
Katherine E. Reeder-Hayes, Stephanie B. Wheeler & Deborah K. Mayer. (2015) Health Disparities Across the Breast Cancer Continuum. Seminars in Oncology Nursing 31:2, pages 170-177.
Crossref
Crossref
M K Farrugia, S B Sharma, C-C Lin, S L McLaughlin, D B Vanderbilt, A G Ammer, M A Salkeni, P Stoilov, Y M Agazie, C J Creighton & J M Ruppert. (2015) Regulation of anti-apoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancer. Cell Death & Disease 6:3, pages e1699-e1699.
Crossref
Crossref
Jose Russo. (2014) Significance of Rat Mammary Tumors for Human Risk Assessment. Toxicologic Pathology 43:2, pages 145-170.
Crossref
Crossref
Y Horimoto, A Arakawa, N Harada-Shoji, H Sonoue, Y Yoshida, T Himuro, F Igari, E Tokuda, O Mamat, M Tanabe, O Hino & M Saito. (2014) Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases. British Journal of Cancer 112:2, pages 345-351.
Crossref
Crossref
Cora G. Uram-Tuculescu & Alida I. Podrumar. 2015. Molecular Oncology Testing for Solid Tumors. Molecular Oncology Testing for Solid Tumors
269
302
.
Debora Fumagalli, Alexis Blanchet-Cohen, David Brown, Christine Desmedt, David Gacquer, Stefan Michiels, Françoise Rothé, Samira Majjaj, Roberto Salgado, Denis Larsimont, Michail Ignatiadis, Marion Maetens, Martine Piccart, Vincent Detours, Christos Sotiriou & Benjamin Haibe-Kains. (2014) Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology. BMC Genomics 15:1.
Crossref
Crossref
Kyueng-Whan Min, Dong-Hoon Kim, Sung-Im Do, Kyungeun Kim, Hyun Joo Lee, Seoung Wan Chae, Jin Hee Sohn, Jung-Soo Pyo, Young-Ha Oh, Wan-Seop Kim, So-Young Lee, Sukjoong Oh, Seon Hyeong Choi, Yong Lai Park & Chan Heun Park. (2014) Expression patterns of stromal MMP-2 and tumoural MMP-2 and -9 are significant prognostic factors in invasive ductal carcinoma of the breast. APMIS 122:12, pages 1196-1206.
Crossref
Crossref
Xiaoping Su, Gabriel G. Malouf, Yunxin Chen, Jianping Zhang, Hui Yao, Vicente Valero, John N. Weinstein, Jean-Philippe Spano, Funda Meric-Bernstam, David Khayat & Francisco J. Esteva. (2014) Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes. Oncotarget 5:20, pages 9864-9876.
Crossref
Crossref
Chi-Cheng Huang, Shih-Hsin Tu, Heng-Hui Lien, Ching-Shui Huang, Chi-Jung Huang, Liang-Chuan Lai, Mon-Hsun Tsai & Eric Y. Chuang. (2014) Refinement of breast cancer risk prediction with concordant leading edge subsets from prognostic gene signatures. Breast Cancer Research and Treatment 147:2, pages 353-370.
Crossref
Crossref
J Sternemalm, H G Russnes, X Zhao, B Risberg, S Nord, C Caldas, A L Børresen-Dale, T Stokke & S Patzke. (2014) Nuclear CSPP1 expression defined subtypes of basal-like breast cancer. British Journal of Cancer 111:2, pages 326-338.
Crossref
Crossref
S. Lindsey Davis, S. Gail Eckhardt, John J. Tentler & Jennifer R. Diamond. (2014) Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkers. Therapeutic Advances in Medical Oncology 6:3, pages 88-100.
Crossref
Crossref
Nagireddy Putluri, Suman Maity, Ramakrishna Kommagani, Chad J. Creighton, Vasanta Putluri, Fengju Chen, Sarmishta Nanda, Salil Kumar Bhowmik, Atsushi Terunuma, Tiffany Dorsey, Agostina Nardone, Xiaoyong Fu, Chad Shaw, Tapasree Roy Sarkar, Rachel Schiff, John P. Lydon, Bert W. O’Malley, Stefan Ambs, Gokul M. Das, George Michailidis & Arun Sreekumar. (2014) Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance. Neoplasia 16:5, pages 390-402.
Crossref
Crossref
Kristine M. CornejoDina KandilAshraf KhanEdiz F. Cosar. (2014) Theranostic and Molecular Classification of Breast Cancer. Archives of Pathology & Laboratory Medicine 138:1, pages 44-56.
Crossref
Crossref
A. Sahin & H. Zhang. 2014. Pathobiology of Human Disease. Pathobiology of Human Disease
934
951
.
Jörg B. Engel, Arnd Honig, Michaela Kapp, Jens C. Hahne, Susanne R. Meyer, Johannes Dietl & Sabine E. Segerer. (2013) Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1. Archives of Gynecology and Obstetrics 289:1, pages 141-147.
Crossref
Crossref
Kyueng-Whan Min, Dong-Hoon Kim, Sung-Im Do, Jung-Soo Pyo, Kyungeun Kim, Seoung Wan Chae, Jin Hee Sohn, Young-Ha Oh, Hong Joo Kim, Seon Hyeong Choi, Yoon Jung Choi & Chan Heun Park. (2012) Diagnostic and Prognostic Relevance of MMP-11 Expression in the Stromal Fibroblast-Like Cells Adjacent to Invasive Ductal Carcinoma of the Breast. Annals of Surgical Oncology 20:S3, pages 433-442.
Crossref
Crossref
Yi-Teng Huang, Fei-Fei Li, Chen Ke, Zhou Li, Zong-Tai Li, Xiao-Fang Zou, Xiao-Xuan Zheng, Yu-Ping Chen & Hao Zhang. (2013) PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy. Journal of Translational Medicine 11:1.
Crossref
Crossref
Geza Acs, John Kiluk, Loretta Loftus & Christine Laronga. (2013) Comparison of Oncotype DX and Mammostrat risk estimations and correlations with histologic tumor features in low-grade, estrogen receptor-positive invasive breast carcinomas. Modern Pathology 26:11, pages 1451-1460.
Crossref
Crossref
Stephanie B. Wheeler, Katherine E. Reeder-Hayes & Lisa A. Carey. (2013) Disparities in Breast Cancer Treatment and Outcomes: Biological, Social, and Health System Determinants and Opportunities for Research. The Oncologist 18:9, pages 986-993.
Crossref
Crossref
AL-Madhagi Radia, AL-Madhagi Yaser, Xiaoqian Ma, Juan Zhang, Cejun Yang, Qiong Dong, Pengfei Rong, Bin Ye, Sheng Liu & Wei Wang. (2013) Specific siRNA Targeting Receptor for Advanced Glycation End Products (RAGE) Decreases Proliferation in Human Breast Cancer Cell Lines. International Journal of Molecular Sciences 14:4, pages 7959-7978.
Crossref
Crossref
Gyula Pekar, Syster Hofmeyer, László Tabár, Miklós Tarján, Tony Hsiu‐Hsi Chen, Amy Ming‐Fang Yen, Sherry Yueh‐Hsia Chiu, Dan Hellberg, Mária Gere & Tibor Tot. (2012) Multifocal breast cancer documented in large‐format histology sections. Cancer 119:6, pages 1132-1139.
Crossref
Crossref
B. Brunetti, P. Asproni, G. Beha, L.V. Muscatello, F. Millanta, A. Poli, C. Benazzi & G. Sarli. (2013) Molecular Phenotype in Mammary Tumours of Queens: Correlation between Primary Tumour and Lymph Node Metastasis. Journal of Comparative Pathology 148:2-3, pages 206-213.
Crossref
Crossref
Jung S. Byun & Kevin Gardner. (2013) C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer. International Journal of Cell Biology 2013, pages 1-14.
Crossref
Crossref
Thomas Decker & Werner Böcker. 2013. Pathologie. Pathologie
183
201
.
Jodi M. Saunus, Amy McCart-Reed, Majid Momeny, Margaret Cummings & Sunil R. Lakhani. 2013. Breast Cancer Metastasis and Drug Resistance. Breast Cancer Metastasis and Drug Resistance
65
95
.
Ayfer Haydaroglu. 2013. Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer. Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer
21
34
.
Alejandro Ariel Gru & Donald Craig Allred. 2013. Molecular Surgical Pathology. Molecular Surgical Pathology
95
128
.
Germana Beha, Barbara Brunetti, Pietro Asproni, Luisa Vera Muscatello, Francesca Millanta, Alessandro Poli, Giuseppe Sarli & Cinzia Benazzi. (2012) Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?. BMC Veterinary Research 8:1.
Crossref
Crossref
Debora Fumagalli, Fabrice Andre, Martine J. Piccart-Gebhart, Christos Sotiriou & Christine Desmedt. (2012) Molecular biology in breast cancer: Should molecular classifiers be assessed by conventional tools or by gene expression arrays?. Critical Reviews in Oncology/Hematology 84, pages e58-e69.
Crossref
Crossref
C. Peñafiel-Verdu, A. J. Buendia, J. A. Navarro, G. A. Ramirez, M. Vilafranca, J. Altimira & J. Sanchez. (2012) Reduced Expression of E-cadherin and β-catenin and High Expression of Basal Cytokeratins in Feline Mammary Carcinomas With Regional Metastasis. Veterinary Pathology 49:6, pages 979-987.
Crossref
Crossref
Melania Costantini, Paolo Belli, Daniela Distefano, Enida Bufi, Marialuisa Di Matteo, Pierluigi Rinaldi, Michela Giuliani, Gianluigi Petrone, Stefano Magno & Lorenzo Bonomo. (2012) Magnetic Resonance Imaging Features in Triple-Negative Breast Cancer: Comparison With Luminal and HER2-Overexpressing Tumors. Clinical Breast Cancer 12:5, pages 331-339.
Crossref
Crossref
Stanley P. L. Leong & Marlys Witte. (2012) Biomarkers of cancer metastasis through the lymphovascular system: future perspectives. Clinical & Experimental Metastasis 29:7, pages 861-864.
Crossref
Crossref
Robin L. Jones, Anastasia Constantinidou & Jorge S. Reis-Filho. (2012) Molecular Classification of Breast Cancer. Surgical Pathology Clinics 5:3, pages 701-717.
Crossref
Crossref
Keith A. Dookeran, James J. Dignam, Nathaniel Holloway, Karen Ferrer, Marin Sekosan, Worta McCaskill-Stevens & Sarah Gehlert. (2012) Race and the Prognostic Influence of p53 in Women with Breast Cancer. Annals of Surgical Oncology 19:7, pages 2334-2344.
Crossref
Crossref
Chung-Chieh Wang, Jau-Yu Liau, Yen-Shen Lu, Jun-Wei Chen, Yu-Tung Yao & Huang-Chun Lien. (2012) Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition. Histopathology 61:1, pages 78-87.
Crossref
Crossref
E. Espinosa, A. Gámez-Pozo, I. Sánchez-Navarro, A. Pinto, C. A. Castañeda, E. Ciruelos, J. Feliu & J. A. Fresno Vara. (2011) The present and future of gene profiling in breast cancer. Cancer and Metastasis Reviews 31:1-2, pages 41-46.
Crossref
Crossref
Cheryl Lin, Meredith Becker Buxton, Dan Moore, Helen Krontiras, Lisa Carey, Angela DeMichele, Leslie Montgomery, Debasish Tripathy, Constance Lehman, Minetta Liu, Olufunmilayo Olapade, Christina Yau, Donald Berry & Laura J. Esserman. (2011) Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Research and Treatment 132:3, pages 871-879.
Crossref
Crossref
Gary J. Kelloff & Caroline C. Sigman. (2012) Cancer biomarkers: selecting the right drug for the right patient. Nature Reviews Drug Discovery 11:3, pages 201-214.
Crossref
Crossref
Patricia J. KellerLisa M. ArendtAdam SkibinskiTanya LogvinenkoIna KlebbaShumin DongAvi E. SmithAleix PratCharles M. PerouHannah GilmoreStuart SchnittStephen P. Naber, Jonathan A. GarlickCharlotte Kuperwasser. (2011) Defining the cellular precursors to human breast cancer. Proceedings of the National Academy of Sciences 109:8, pages 2772-2777.
Crossref
Crossref
Irene K. Guttilla, Brian D. Adams & Bruce A. White. (2012) ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer. Trends in Endocrinology & Metabolism 23:2, pages 73-82.
Crossref
Crossref
Jessica Kalra & Lincoln A. Edwards. (2012) Breast Cancer Therapies Present and Future. Journal of Cancer Therapy 03:06, pages 1140-1150.
Crossref
Crossref
Felipe C. Geyer, Daniel N. Rodrigues, Britta Weigelt & Jorge S. Reis-Filho. (2012) Molecular Classification of Estrogen Receptor-positive/Luminal Breast Cancers. Advances in Anatomic Pathology 19:1, pages 39-53.
Crossref
Crossref
Stephanie B. Wheeler, William R. Carpenter, Jeffrey Peppercorn, Anna P. Schenck, Morris Weinberger & Andrea K. Biddle. (2011) Predictors of timing of adjuvant chemotherapy in older women with hormone receptor–negative, stages II–III breast cancer. Breast Cancer Research and Treatment 131:1, pages 207-216.
Crossref
Crossref
Lee H. Chen, Wen-Hung Kuo, Mong-Hsun Tsai, Pei-Chun Chen, Chuhsing K. Hsiao, Eric Y. Chuang, Li-Yun Chang, Fon-Jou Hsieh, Liang-Chuan Lai & King-Jen Chang. (2011) Identification of Prognostic Genes for Recurrent Risk Prediction in Triple Negative Breast Cancer Patients in Taiwan. PLoS ONE 6:11, pages e28222.
Crossref
Crossref
Amanda K. Smolarek & Nanjoo Suh. (2011) Chemopreventive Activity of Vitamin E in Breast Cancer: A Focus on γ- and δ-Tocopherol. Nutrients 3:11, pages 962-986.
Crossref
Crossref
Richard L Schilsky. (2011) Drug approval challenges in the age of personalized cancer treatment. Personalized Medicine 8:6, pages 633-640.
Crossref
Crossref
Pierre-Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt & Jorge S Reis-Filho. (2011) Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction. Breast Cancer Research 13:3.
Crossref
Crossref
E. R. C. G. N. Galvão, L. M. S. Martins, J. O. Ibiapina, H. M. Andrade & S. J. H. Monte. (2011) Breast cancer proteomics: a review for clinicians. Journal of Cancer Research and Clinical Oncology 137:6, pages 915-925.
Crossref
Crossref
Aaron M. Gruver, Bryce P. Portier & Raymond R. Tubbs. (2011) Molecular Pathology of Breast Cancer: The Journey From Traditional Practice Toward Embracing the Complexity of a Molecular Classification. Archives of Pathology & Laboratory Medicine 135:5, pages 544-557.
Crossref
Crossref
Alan Mackay, Britta Weigelt, Anita Grigoriadis, Bas Kreike, Rachael Natrajan, Roger A’Hern, David S.P. Tan, Mitch Dowsett, Alan Ashworth & Jorge S. Reis-Filho. (2011) Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement. JNCI: Journal of the National Cancer Institute 103:8, pages 662-673.
Crossref
Crossref
Theresa A. Proia, Patricia J. Keller, Piyush B. Gupta, Ina Klebba, Ainsley D. Jones, Maja Sedic, Hannah Gilmore, Nadine Tung, Stephen P. Naber, Stuart Schnitt, Eric S. Lander & Charlotte Kuperwasser. (2011) Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate. Cell Stem Cell 8:2, pages 149-163.
Crossref
Crossref
Aleix Prat & Charles M. Perou. (2011) Deconstructing the molecular portraits of breast cancer. Molecular Oncology 5:1, pages 5-23.
Crossref
Crossref
Konstantin J. Dedes, Paul M. Wilkerson & Jorge S. Reis-Filho. 2011. Breast Cancer, a Heterogeneous Disease Entity. Breast Cancer, a Heterogeneous Disease Entity
119
148
.
Britta Weigelt & Jorge S Reis-Filho. (2010) Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry. Breast Cancer Research 12:S4.
Crossref
Crossref
Alfonso Sánchez-Muñoz, Elena Gallego, Vanessa de Luque, Luís G Pérez-Rivas, Luís Vicioso, Nuria Ribelles, José Lozano & Emilio Alba. (2010) Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer. BMC Cancer 10:1.
Crossref
Crossref
Kathryn Mary Verbanac, Christopher Justus Min, Ann Elizabeth Mannie, Jianfen Lu, Kevin F. O’Brien, Martin Rosman & Lorraine Tafra. (2010) Long-Term Follow-up Study of a Prospective Multicenter Sentinel Node Trial: Molecular Detection of Breast Cancer Sentinel Node Metastases. Annals of Surgical Oncology 17:S3, pages 368-377.
Crossref
Crossref
Benjamin Haibe-Kains. (2010) Classification Models for Breast Cancer Molecular Subtyping: What is the Best Candidate for a Translation into Clinic?. Women's Health 6:5, pages 623-625.
Crossref
Crossref
Emad A Rakha, Jorge S Reis-Filho, Frederick Baehner, David J Dabbs, Thomas Decker, Vincenzo Eusebi, Stephen B Fox, Shu Ichihara, Jocelyne Jacquemier, Sunil R Lakhani, José Palacios, Andrea L Richardson, Stuart J Schnitt, Fernando C Schmitt, Puay-Hoon Tan, Gary M Tse, Sunil Badve & Ian O Ellis. (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Research 12:4.
Crossref
Crossref
Eva Szabo. (2010) Phase II Cancer Prevention Clinical Trials. Seminars in Oncology 37:4, pages 359-366.
Crossref
Crossref
Ann F. Chambers, Eva A. Turley, John Lewis & Leonard G. Luyt. 2010. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer
397
417
.
Hege G. RussnesHans Kristian Moen VollanOle Christian LingjærdeAlexander KrasnitzPär LundinBjørn NaumeTherese SørlieElin BorgenInga H. RyeAnita LangerødSuet-Feung ChinAndrew E. TeschendorffPhilip J. StephensSusanne MånérEllen SchlichtingLars O. BaumbuschRolf KåresenMichael P. StrattonMichael WiglerCarlos CaldasAnders ZetterbergJames HicksAnne-Lise Børresen-Dale. (2010) Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients. Science Translational Medicine 2:38.
Crossref
Crossref
Britta Weigelt, Felipe C. Geyer & Jorge S. Reis-Filho. (2010) Histological types of breast cancer: How special are they?. Molecular Oncology 4:3, pages 192-208.
Crossref
Crossref
Jeffrey PeppercornIuliana ShapiraDeborah CollyarTeresa DeshieldsNancy LinIan KropHans GrunwaldPaula FriedmanAnn H. PartridgeRichard L. SchilskyMonica M. Bertagnolli. (2010) Ethics of Mandatory Research Biopsy for Correlative End Points Within Clinical Trials in Oncology. Journal of Clinical Oncology 28:15, pages 2635-2640.
Crossref
Crossref
Keith A. Dookeran, James J. Dignam, Karen Ferrer, Marin Sekosan, Worta McCaskill-Stevens & Sarah Gehlert. (2010) p53 as a Marker of Prognosis in African-American Women with Breast Cancer. Annals of Surgical Oncology 17:5, pages 1398-1405.
Crossref
Crossref
Richard L. Schilsky. (2010) Personalized medicine in oncology: the future is now. Nature Reviews Drug Discovery 9:5, pages 363-366.
Crossref
Crossref
Jorma de Ronde, Lodewyk Wessels & Jelle Wesseling. (2010) Molecular subtyping of breast cancer: ready to use?. The Lancet Oncology 11:4, pages 306-307.
Crossref
Crossref
Britta Weigelt, Alan Mackay, Roger A'hern, Rachael Natrajan, David SP Tan, Mitch Dowsett, Alan Ashworth & Jorge S Reis-Filho. (2010) Breast cancer molecular profiling with single sample predictors: a retrospective analysis. The Lancet Oncology 11:4, pages 339-349.
Crossref
Crossref
K.A. Dookeran. (2010) Age/Race Differences in HER2 Testing and in Incidence Rates for Breast Cancer Triple Subtypes: A Population-Based Study and First Report. Breast Diseases: A Year Book Quarterly 21:4, pages 338-340.
Crossref
Crossref
SUSAN C. LESTER. 2010. Robbins and Cotran Pathologic Basis of Disease. Robbins and Cotran Pathologic Basis of Disease
1065
1095
.
Britta Weigelt, Frederick L Baehner & Jorge S Reis-Filho. (2010) The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. The Journal of Pathology 220:2, pages 263-280.
Crossref
Crossref
Britta Weigelt & Jorge S. Reis-Filho. (2009) Histological and molecular types of breast cancer: is there a unifying taxonomy?. Nature Reviews Clinical Oncology 6:12, pages 718-730.
Crossref
Crossref
. (2009) Surveillance après traitement de cancer du sein (hors mutation). Oncologie 11:11, pages 589-610.
Crossref
Crossref
Ping Tang, Kristin A. Skinner & David G. Hicks. (2009) Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis. Diagnostic Molecular Pathology 18:3, pages 125-132.
Crossref
Crossref
Brian D. Adams, Danielle M. Cowee & Bruce A. White. (2009) The Role of miR-206 in the Epidermal Growth Factor (EGF) Induced Repression of Estrogen Receptor-α (ERα) Signaling and a Luminal Phenotype in MCF-7 Breast Cancer Cells. Molecular Endocrinology 23:8, pages 1215-1230.
Crossref
Crossref
Karen Y. Dane, Claudia Gottstein & Patrick S. Daugherty. (2009) Cell surface profiling with peptide libraries yields ligand arrays that classify breast tumor subtypes. Molecular Cancer Therapeutics 8:5, pages 1312-1318.
Crossref
Crossref
Tushar Vora, Evandro de Azambuja, Ahmad Awada & Martine Piccart. (2009) Novel therapeutics in breast cancer—Looking to the future. Update on Cancer Therapeutics 3:4, pages 189-205.
Crossref
Crossref
Ji Eun Uhm, Yeon Hee Park, Seong Yoon Yi, Eun Yoon Cho, Yoon La Choi, Su Jin Lee, Min Jae Park, Se-Hoon Lee, Hyun Jung Jun, Jin Seok Ahn, Won Ki Kang, Keunchil Park & Young-Hyuck Im. (2009) Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy. International Journal of Cancer 124:6, pages 1457-1462.
Crossref
Crossref
Bhuvaneswari RamaswamySarmila MajumderSatavisha RoyKalpana GhoshalHuban KutayJharna DattaMamoun Younes, Charles L. ShapiroTasneem MotiwalaSamson T. Jacob. (2009) Estrogen-Mediated Suppression of the Gene Encoding Protein Tyrosine Phosphatase PTPRO in Human Breast Cancer: Mechanism and Role in Tamoxifen Sensitivity. Molecular Endocrinology 23:2, pages 176-187.
Crossref
Crossref
Maurizio Zarcone, Rosalba Amodio, Ildegarda Campisi, Rosanna Cusimano, Cecilia Dolcemascolo, Vitale Miceli, Adele Traina & Maurizio Macaluso. (2009) Application of a New Classification to a Breast Tumor Series from a Population-Based Cancer Registry. Annals of the New York Academy of Sciences 1155:1, pages 222-226.
Crossref
Crossref
Barry Gusterson. (2008) Do 'basal-like' breast cancers really exist?. Nature Reviews Cancer 9:2, pages 128-134.
Crossref
Crossref
Vikas Sehdev, James C. K. Lai & Alok Bhushan. (2009) Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells. Journal of Oncology 2009, pages 1-10.
Crossref
Crossref
Patricia NoelWeiniu GanJames Kiley. (2008) Molecular phenotyping for severe asthma. Personalized Medicine 5:3, pages 301-304.
Crossref
Crossref
Rowan T Chlebowski. (2008) Pre-Empting Breast Cancer: Where Do we Go from Here?. Women's Health 4:2, pages 113-114.
Crossref
Crossref